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Daily physical activity
in subjects with newly
diagnosed COPD
Rationale Information about daily physical
activity levels (PAL) in subjects with
undiagnosed chronic obstructive pulmonary
disease (COPD) is scarce. This study aims to
assess PA and to investigate the associations
between PA and clinical characteristics in
subjects with newly diagnosed COPD.
Methods Fifty-nine subjects with a new
spirometry-based diagnosis of mild (n=38) and
moderate (n=21) COPD (63±6 years, 68%
male) were matched with 65 smoking controls
(62±7 years, 75% male). PA (daily steps, time
spent in moderate-to-vigorous intense physical
activities (MVPA) and PAL) was measured by
accelerometry. Dyspnoea, complete pulmonary
function tests, peripheral muscle strength and
exercise capacity served as clinical
characteristics.
Results PA was significantly lower in COPD
versus smoking controls (7986±2648 vs 9765
±3078 steps, 64 (27–120) vs 110 (55–164)
min of MVPA, 1.49±0.21 vs 1.62±0.24 PAL
respectively, all p<0.05). Subjects with COPD
with either mild symptoms of dyspnoea
(mMRC 1), those with lower diffusion capacity
(TL,co), low 6 min walking distance (6MWD)
or low maximal oxygen uptake (VO2 peak)
had significantly lower PA. Multiple regression
analysis identified 6 MWD and TL,co as
independent predictors of PA in COPD.
Conclusions The reduction in PA starts early
in the disease, even when subjects are not yet
diagnosed with COPD. Inactivity is more
pronounced in subjects with mild symptoms of
dyspnoea, lower levels of diffusion capacity
and exercise capacity.
The detection of an inactive lifestyle in
patients with chronic obstructive pulmon-
ary disease (COPD) is increasingly import-
ant since inactivity predicts prognosis in
COPD1 and may even impact on the rate
of lung function decline.2 Data on daily
physical activity levels (PAL) are lacking
regarding patients unaware of their
disease in whom the diagnosis of COPD
is based on spirometry screening (preclin-
ical stage). We aimed to objectively inves-
tigate daily PALs and to investigate the
association between physical activity and
different clinical characteristics in subjects
with newly spirometry-based diagnosis of
COPD.
Hundred and twenty-four (ex-) smokers
were recruited from a population-based
sample (see online supplementary figure S1).
Fifty-nine subjects with a new spirometry-
based diagnosis of mild (n=38) and moder-
ate (n=21) COPD (63±6 years, 68% male)
were matched with 65 smoking controls (62
±7 years, 75% male). Detailed characteris-
tics of the study subjects are summarised in
online supplementary table S1. Physical
activity (daily steps, time spent in
moderate-to- vigorous intense physical activ-
ities (MVPA) and PAL) was measured by a
multi-sensor activity monitor (SenseWear
Pro 3 Armband). Dyspnoea, complete pul-
monary function tests, peripheral muscle
strength and exercise capacity served as clin-
ical characteristics. Additional information
on material and methods is available in the
online supplementary.
We found that physical activity was sig-
nificantly lower in COPD compared to
smoking controls (figure 1). Subjects with
COPD with either mild symptoms of dys-
pnoea (mMRC 1), those with lower
diffusion capacity (TL,co), low 6 min
walking distance (6MWD) or low maximal
oxygen uptake (VO2 peak) had signifi-
cantly lower PALs (see online
supplementary figure S2–S5). COPD sub-
jects and smoking controls with lower
levels of isometric quadriceps force did
not show lower daily PALs. Multiple
regression analysis identified 6MWD and
TL,co as independent predictors of phys-
ical activity in COPD (see online
supplementary table S2).
Our data support the recent advice of
Centers for Disease Control and
Prevention that physical activity is an
important vital sign, even in patients with
mild disease.3
Several cross-sectional studies found
that patients with an established diagnosis
of mild-to-moderate COPD, recruited in
hospital outpatient settings, were physic-
ally inactive compared to a (non-)
smoking control group.4 5 This is the first
study that showed that early reduction in
physical activity is already present in sub-
jects with mild-to-moderate COPD who
did not previously present to healthcare
services (ie, preclinical stage). Of import-
ance to clinicians is the finding that some
clinical characteristics (mild symptoms of
dyspnoea, low values of diffusion capacity
and exercise capacity) may identify the
inactive subjects. In this group, early
therapeutic interventions such as activity
counselling programmes could be helpful
in preventing deterioration of the PALs,
and by consequence, other clinical out-
comes such as comorbidity and disease
progression.2 We conclude that the reduc-
tion in physical activity starts early in the
disease, even when subjects are not yet
diagnosed with COPD, especially in those
Figure 1 Daily physical activity levels (PAL) in subjects with and without chronic obstructive pulmonary disease (COPD); daily steps (A) 7986±2648
vs 9765±3078 steps, daily time spent in moderate-to-vigorous physical activity (MVPA) (B) 64 (27–120) vs 110 (55–164) min of MVPA and daily
PAL (C): 1.49±0.21 vs 1.62±0.24 PAL. *p<0.05 COPD versus smoking controls.
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with mild symptoms of dyspnoea, lower
levels of diffusion capacity and exercise
capacity.
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